Skip to main content

Table 2 Patient characteristics according to the Scheuer fibrosis stage

From: The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China

Characteristic F0(n = 12)* F1(n = 18) F2(n = 21) F3(n = 19) F4(n = 21) P
Age (year) 32.25 ± 10.36 38.17 ± 10.99 40.90 ± 11.45 43.68 ± 12.37 46.33 ± 13.46 0.018
Male/female§ 7/5 9/9 12/9 10/9 11/10 0.988#
ALT (IU/L) 60.67 ± 17.84 83.22 ± 54.43 83.30 ± 57.13 94.21 ± 74.63 105.35 ± 75.36 0.345
AST (IU/L) 35.58 ± 16.22 35.08 ± 21.16 41.46 ± 26.34 52.58 ± 38.82 60.18 ± 39.41 0.066
GGT (IU/L) 46.50 ± 32.95 55.53 ± 38.34 90.49 ± 53.86 104.32 ± 99.57 136.96 ± 110.49 0.006
PLT (109/L) 254.08 ± 72.08 194.50 ± 50.08 182.76 ± 47.16 159.42 ± 79.28 107.33 ± 40.92 < 0.001
  1. Data are presented as the mean ± standard deviation and analysed by analysis of variance (ANOVA) unless indicated. ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transpeptidase, PLT platelet count, APRI aspartate aminotransferase-to-platelet ratio index, FIB-4 fibrosis index based on four factors, LFI liver fibrosis index. *Number in each fibrosis stage. §Number of males and females. #Chi-square test